home← all complexes Ir builderC^N familiesD-MPNN

Complex #2048 — Ru(2) [Ru(phen)2(Hecip)]

2D Structure

Structure
⬇ MOL V3000

Info

ID2048
MetalRu
Oxidation state2
Charge2
Donor atoms{"N": 6}
AbbreviationRu(phen)2(Hecip)
SMILESCCn1c2ccccc2c2cc(-c3nc4c5cccnc5c5ncccc5c4[nH]3)ccc21.c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12

TUCAN

C51H35N9Ru/(1-75)(2-69)(3-44)(4-75)(5-43)(6-53)(7-38)(8-70)(9-73)(10-37)(11-42)(12-39)(13-47)(14-40)(15-48)(16-56)(17-36)(18-36)(19-36)(20-49)(21-71)(22-57)(23-52)(24-72)(25-74)(26-51)(27-50)(28-41)(29-45)(30-58)(31-59)(32-46)(33-54)(34-55)(35-88)(36-75)(37-55)(37-60)(38-40)(38-60)(39-41)(39-63)(40-69)(41-66)(42-48)(42-63)(43-47)(43-71)(44-59)(44-79)(45-46)(45-72)(46-61)(47-62)(48-70)(49-51)(49-73)(50-54)(50-74)(51-66)(52-58)(52-65)(53-56)(53-83)(54-67)(55-67)(56-64)(57-64)(57-68)(58-59)(60-76)(61-81)(61-85)(62-80)(62-84)(63-77)(64-86)(65-68)(65-79)(66-78)(67-82)(68-83)(69-90)(70-91)(71-87)(72-95)(73-92)(74-94)(75-89)(76-82)(76-90)(77-78)(77-91)(78-92)(79-89)(80-81)(80-88)(81-93)(82-94)(83-89)(84-85)(84-87)(85-95)(86-88)(86-93)(90-96)(91-96)(92-96)(93-96)(94-96)(95-96)

Measurements (4)

Cell lineIC₅₀ dark (µM)IC₅₀ light (µM)DOIYear
SK-BR-38.6— 10.1371/journal.pone.0096082 2014
A5499.6— 10.1371/journal.pone.0096082 2014
BEL-740211— 10.1371/journal.pone.0096082 2014
MG-6315— 10.1371/journal.pone.0096082 2014

🧬 Cell Death Types (1)

Apoptosis high
«The apoptotic study indicates that complexes 1 and 2 can effectively induce apoptosis of BEL-7402 cells and inhibit the proliferation in the G0/G1 phase on BEL-7402 cells. Additionally, complexes 1 an...»

Source-assisted 2D generator

Builds the drawing from source ligand graphs and explicit donor metadata, then uses Metal2D only for layout. Publication output uses black bonds without arrows or colour highlighting; validated octahedral enantiomers are encoded directly with solid and hashed wedge bonds.

experimental validation surface
Loading source metadata…
The generated SVG will appear here. The legacy ligand image above stays visible for side-by-side review.